Development and subsequent refinement of the inflammatory bowel disease questionnaire: A quality-of-life instrument for adult patients with inflammatory bowel disease

Journal of Pediatric Gastroenterology and Nutrition

Volumn 28, Issue 4, 1999, Pages

  Irvine, E Jan ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Crohn's disease; Health status instrument; Index of health; Office practice; Quality of life; Questionnaire; Ulcerative colitis

Indexed keywords

ARTICLE; EMOTION; ENTERITIS; HUMAN; INTESTINE FUNCTION; PRIORITY JOURNAL; QUALITY OF LIFE; SOCIAL BEHAVIOR; SOCIAL STATUS;

ADULT; HEALTH STATUS; HUMANS; INFLAMMATORY BOWEL DISEASES; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 0033498677     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199904001-00003     Document Type: Article

References (14)

1. Guyatt GH, Feeny DH, Patrick DL. Measuring health related quality of life in chronic disease. Ann Intern Med 1993;118:622-29.
2. Fitzpatrick R, Fletcher A, Gore S, et al. Quality of life measures in health care. I: Applications and issues in assessment. BMJ 1992; 305:1074-77.
3. Guyatt GH, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in IBD. Gastroenterology 1989;96:804-10.
4. Mitchell A, Guyatt G, Singer J, et al. Quality of life in patients with IBD. J Clin Gastroenterol 1988;10:306-10.
5. Guyatt GH, Walter S, Norman G. Measuring change over time: Assessing the usefulness of evaluative instruments. J Chronic Dis 1987;40:171-8.
6. Ware JE, Brook RR, Davies-Avery A, et al. Conceptualization and measurement of health for adults in the health insurance study. Vol 1, Model of Health and Methodology. Santa Monica, CA: Rand Corporation, 1980, May. Report No. R-1987-HEW. Grant Nos: 016B-7501-P2021, 016B-7601-P2021, and 016B-7901-P2021. 49 pp. Prepared under a grant from the US Department of Health, Education, and Welfare.
7. Irvine EJ, Feagan B, Rochon J, et al. Quality of life: A valid and reliable measure of outcome for clinical trials in inflammatory bowel disease. Gastroenterology 1994;106:287-96.
8. Feagan B, McDonald JWD, Rochon J, et al. Chronic low dose cyclosporine in the treatment of Crohn's disease. N Engl J Med 1994:330:1846-51.
9. Martin F, Sutherland L, Beck IT, et al. Oral 5ASA versus prednisone in short term treatment of Crohn's disease: A multicentre controlled trial. Can J Gastroenterol 1990;4:452-7.
10. Greenberg GR, Feagan BG, Martin FM, et al. Oral budesonide for active Crohn's disease. N Engl J Med 1994;331:836-41.
11. Feagan BG, Rochon J, Fedorak RN, et al. Methotrexate for the treatment of Crohn's disease. N Engl J Med 1995;332:292-7.
12. Irvine EJ, Donnelly M. Quality of life is comparably impaired in patients with ulcerative colitis and irritable bowel syndrome (abstract). Gastroenterology 1994;106:A517.
13. Irvine EJ, Feagan B, Wong C. Does self-administration of a quality of life instrument change the results? J Clin Epidemiol 1996;49: 1177-85.
14. Irvine EJ, Zhou Q, Thompson A and the CCRPT Investigators. The short IBDQ: A quality of life instrument for community physicians managing inflammatory bowel disease. Am J Gastroenterol 1996; 91:1571-78.